Polypeptide Laboratories Inc.

Form 483 issued August 30, 2019 · Torrance, California

Inspection
Aug 26 – Aug 30, 2019
Observations
1
Pages
3
FEI number
1000519239

In short: On August 30, 2019, FDA issued a Form 483 with 1 observation to Polypeptide Laboratories Inc. in Torrance, California (FEI 1000519239) after an inspection that ran Aug 26 – Aug 30, 2019. The investigator was Santiago Gallardo Johnson. Most observations concern quality system; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

1 of 1 observations on this 483 concern quality system.

Quality system1

Most cited: 21 CFR 211.192 (1×) · 211.198 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Failure to follow established…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Polypeptide Laboratories Inc.?

FDA listed 1 observation on this Form 483, mostly about quality system. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Polypeptide Laboratories Inc.?

Santiago Gallardo Johnson is named on this Form 483, for the inspection of Aug 26 – Aug 30, 2019. Each investigator has a profile showing what they cite most.

When was Polypeptide Laboratories Inc. inspected by FDA?

The inspection ran Aug 26 – Aug 30, 2019, and the Form 483 is dated August 30, 2019.

How do I get the full Form 483 for Polypeptide Laboratories Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free